Fig. 3From: Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment optionsKaplan-Meier curve of the 30-day survival probability of all patients with CRE BSI (a) patients with and without septic shock (b) patients with and without pulmonary infection (c) patients with ceftazidime-avibactam (CAZ-AVI) or other active antibiotics (OAAs) treatment (d)Back to article page